The existing authors performed an open-label pilot examine that administered psilocybin to fifteen procedure-resistant tobacco/nicotine-dependent smokers, inside the context of cognitive behavioral therapy for smoking cigarettes cessation [fifty eight]. Members were being administered ~0.29 mg/kg oral psilocybin on the participant’s target date t